Ongororo yakanyorwa nevechidiki, MD, Anderson Cancer Center, USA yakatsanangura mashandisiro ePD-1 inhibitor immunotherapy muB-cell lymphoma. (Ropa. Vhezheni yepamhepo muna Mbudzi 8, 2017. doi: 10.1182 / blood-2017-07-740993.) PD-1 immune ..
Iyo Cleveland Clinic yeUnited States Eric D. Wake et al. Yakataurwa kuti kuongororwa kwehutachiona T cell lymphoma (PTCL) muUnited States inosiyana zvakanyanya, uye kazhinji haina ruzivo rwakakosha rwe phenotypic kunyatso kusiyanisa ..
Vakura T-cell tumors, senge isiri-Hodgkin T-cell lymphoma, inokonzeresa uye haina mishonga, uye varwere vanowanzo kuve nehurombo hwekufungidzira. Munguva pfupi yapfuura, "Zvisikwa" zvakateedzana zvinyorwa zviviri zvakaburitsa kududzira kutsva kwepathogene ..
Kufutisa hakusi kungopesana neaesthetics yevanhu, asiwo kunokonzera zvirwere zvakawanda zvisingaperi. Zvimwe zvidzidzo zvakaratidza kuti body mass index (BMI) ine chekuita nenjodzi yegomarara mune zvimwe zvikamu (senge digestive system).
Nezuro, iyo US FDA yakazivisa kubvumidzwa kwaSeattle Genetics 'antibody-drug conjugate Adcetris (brentuximab vedotin) mukubatana nekemotherapy kune varwere vakamborapwa nhanho yechitatu kana IV yechinyakare Hodgkin's lymph ..
New Cleveland Clinic tsvagiridzo inoratidza kekutanga kuti FDA-inogamuchirwa ibrutinib (ibrutinib) ye lymphoma neleukemia inogona zvakare kubatsira kurapa akajairika uye anouraya matumbo ehuropi, uye rinogona rimwe zuva kushandiswa kune varwere vane gliobla ..
Bone marrow fibrosis chirwere chisingawanzo chisingaperi chemwongo wemapfupa hematopoietic masero. Vanobatsirwa kubva kuJAK2 inhibitor zvinodhaka: kuregererwa kwechiratidzo, kurarama kwenguva refu, uye hupenyu huri nani. Nekudaro, makore maviri kana matatu mushure mekutanga..
Musi waChikumi 12-13, FDA yakatendera zviratidzo zviviri zvitsva zvemushonga weK, kwangosara zuva rimwe chete mushonga weK usati watenderwa kurapwa gomarara rechibereko. Rimwe zuva gare gare, iyo US FDA yakabvumidza pembrolizumab (Keytruda, pembrolizumab) yetrea.
MuUnited States, vanhu vanopfuura 70,000 XNUMX vanoonekwa kuti vane non-Hodgkin's lymphoma gore negore, izvo zvinokonzerwa nekuwanda kwemasero ekudzivirira muviri mumalymph nodes emuviri. Iyo inonyanya kuzivikanwa ndeyekuparadzira B-cell limp..
Mumakore achangopfuura, mhedzisiro yeimmune checkpoint inhibitors pakurapa kweHodgkin's lymphoma (HL) inoshamisa, asi chirwere ichi chinoda kukundwa zvakanyanya. Sachigaro weMayo Clinic's Lymphoma Group Ansell akati.